Literature DB >> 22447418

[Ophthalmic agents during pregnancy and breastfeeding].

T Ness1, W Paulus.   

Abstract

Ocular therapy is necessary even during pregnancy but the use of pharmaceutical substances bears the risk of side effects on mother and child. The article reflects current knowledge on how to treat the most important eye diseases during pregnancy and breastfeeding. The review covers the diagnostics (tonometry, mydriasis, angiography) as well as treatment of infections of the eyes, glaucoma, allergies, diabetic retinopathy, pain and inflammation.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22447418     DOI： 10.1007/s00347-011-2459-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  29 in total

1.  The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).

Authors: 
Journal:  Ann Allergy Asthma Immunol       Date:  2000-05       Impact factor: 6.347

Review 2.  Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study.

Authors:  Christina Chambers; Gideon Koren; Zuhre N Tutuncu; Diana Johnson; Kenneth L Jones
Journal:  Can Fam Physician       Date:  2007-03       Impact factor: 3.275

3.  Topical timolol therapy in pregnancy: is it safe for the fetus?

Authors:  A M Wagenvoort; J M van Vugt; M Sobotka; H P van Geijn
Journal:  Teratology       Date:  1998-12

4.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

5.  The use of acetazolamide in idiopathic intracranial hypertension during pregnancy.

Authors:  Andrew G Lee; Misha Pless; Julie Falardeau; Tammy Capozzoli; Michael Wall; Randy H Kardon
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

6.  Pharmacokinetics of three newer quinolones in pregnant and lactating women.

Authors:  H Giamarellou; E Kolokythas; G Petrikkos; J Gazis; D Aravantinos; P Sfikakis
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

7.  Maternal corticosteroid use and risk of selected congenital anomalies.

Authors:  S L Carmichael; G M Shaw
Journal:  Am J Med Genet       Date:  1999-09-17

8.  Management of pregnancy in transplant recipients.

Authors:  P Sivaraman
Journal:  Transplant Proc       Date:  2004-09       Impact factor: 1.066

9.  Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Authors:  Suzanne M M Verstappen; Yvonne King; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2011-02-28       Impact factor: 19.103

Review 10.  Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.

Authors:  Javier P Gisbert
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325
View more
  3 in total

Review 1.  Ocular changes during pregnancy.

Authors:  Friederike Mackensen; Wolfgang E Paulus; Regina Max; Thomas Ness
Journal:  Dtsch Arztebl Int       Date:  2014-08-18       Impact factor: 5.594

2.  [Medical myths in ophthalmology].

Authors:  T U Krohne
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

Review 3.  [Possibilities and limitations of eye drops for glaucoma therapy].

Authors:  I M Lanzl; M Poimenidou; G L Spaeth
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.